FENC logo

Fennec Pharmaceuticals (FENC) Operating Expenses

Annual Operating Expenses

$33.05 M
+$8.86 M+36.65%

December 31, 2023


Summary


Performance

FENC Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCexpensesmetrics:

Quarterly Operating Expenses

$10.84 M
-$853.00 K-7.29%

September 30, 2024


Summary


Performance

FENC Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

FENC Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+36.6%-7.3%
3 y3 years+83.1%+56.6%
5 y5 years+217.5%+56.6%

FENC Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+91.9%-7.3%+205.1%
5 y5-yearat high+154.1%-7.3%+208.3%
alltimeall timeat high+1958.5%-7.3%+2335.1%

Fennec Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$10.84 M(-7.3%)
Jun 2024
-
$11.69 M(+5.3%)
Mar 2024
-
$11.10 M(+1.5%)
Dec 2023
$33.05 M(+36.6%)
$10.94 M(+50.4%)
Sep 2023
-
$7.27 M(-7.3%)
Jun 2023
-
$7.84 M(+13.3%)
Mar 2023
-
$6.92 M(-9.5%)
Dec 2022
$24.19 M(+40.4%)
$7.65 M(-3.9%)
Sep 2022
-
$7.96 M(+59.0%)
Jun 2022
-
$5.01 M(+41.0%)
Mar 2022
-
$3.55 M(-15.5%)
Dec 2021
$17.22 M(-4.6%)
$4.21 M(+0.8%)
Sep 2021
-
$4.17 M(+6.5%)
Jun 2021
-
$3.92 M(-20.4%)
Mar 2021
-
$4.92 M(+40.0%)
Dec 2020
$18.05 M(+38.8%)
$3.52 M(-40.0%)
Sep 2020
-
$5.86 M(+20.9%)
Jun 2020
-
$4.84 M(+26.3%)
Mar 2020
-
$3.83 M(+5.0%)
Dec 2019
$13.01 M(+25.0%)
$3.65 M(+96.1%)
Sep 2019
-
$1.86 M(-61.3%)
Jun 2019
-
$4.81 M(+79.6%)
Mar 2019
-
$2.68 M(-13.7%)
Dec 2018
$10.41 M(+49.7%)
$3.10 M(+9.0%)
Sep 2018
-
$2.85 M(+6.9%)
Jun 2018
-
$2.67 M(+48.8%)
Mar 2018
-
$1.79 M(-28.8%)
Dec 2017
$6.95 M(+142.1%)
$2.52 M(+15.1%)
Sep 2017
-
$2.19 M(+47.8%)
Jun 2017
-
$1.48 M(+91.8%)
Mar 2017
-
$771.00 K(-32.7%)
Dec 2016
$2.87 M(+51.9%)
$1.15 M(+103.2%)
Sep 2016
-
$564.00 K(-20.2%)
Jun 2016
-
$707.00 K(+55.7%)
Mar 2016
-
$454.00 K(-17.6%)
Dec 2015
$1.89 M(-34.3%)
$551.00 K(+63.0%)
Sep 2015
-
$338.00 K(-38.4%)
Jun 2015
-
$549.00 K(+21.5%)
Mar 2015
-
$452.00 K(-42.9%)
Dec 2014
$2.88 M(+49.0%)
$791.00 K(+27.8%)
Sep 2014
-
$619.00 K(-33.4%)
Jun 2014
-
$930.00 K(+73.2%)
Mar 2014
-
$537.00 K(+29.1%)
Dec 2013
$1.93 M(-46.7%)
$416.00 K(+715.7%)
Sep 2013
-
$51.00 K(-94.5%)
Jun 2013
-
$927.00 K(+72.6%)
Mar 2013
-
$537.00 K(-52.2%)
DateAnnualQuarterly
Dec 2012
$3.62 M(+5.3%)
$1.12 M(+78.3%)
Sep 2012
-
$630.00 K(-49.6%)
Jun 2012
-
$1.25 M(+102.9%)
Mar 2012
-
$616.00 K(-31.7%)
Dec 2011
$3.44 M(-25.3%)
$902.00 K(-4.4%)
Sep 2011
-
$944.00 K(+65.0%)
Jun 2011
-
$572.00 K(-44.0%)
Mar 2011
-
$1.02 M(+25.1%)
Dec 2010
$4.60 M(+62.7%)
$816.00 K(-11.0%)
Sep 2010
-
$917.00 K(-63.4%)
Jun 2010
-
$2.50 M(+584.4%)
Mar 2010
-
$366.00 K(-175.5%)
Dec 2009
$2.83 M(-79.6%)
-$485.00 K(-755.4%)
Sep 2009
-
$74.00 K(-92.3%)
Jun 2009
-
$961.00 K(-50.8%)
Mar 2009
-
$1.95 M(-26.1%)
Dec 2008
$13.89 M(-2.1%)
$2.64 M(-20.0%)
Sep 2008
-
$3.30 M(-6.0%)
Jun 2008
-
$3.51 M(-20.9%)
Mar 2008
-
$4.44 M(+39.5%)
Dec 2007
$14.19 M(-25.6%)
$3.18 M(-8.0%)
Sep 2007
-
$3.46 M(+0.5%)
Jun 2007
-
$3.44 M(-16.4%)
Mar 2007
-
$4.12 M(-41.3%)
Dec 2006
$19.06 M(+3.9%)
$7.01 M(+46.9%)
Sep 2006
-
$4.77 M(+19.9%)
Jun 2006
-
$3.98 M(+20.3%)
Mar 2006
-
$3.31 M(-36.3%)
Dec 2005
$18.35 M(+94.7%)
$5.19 M(+8.1%)
Sep 2005
-
$4.80 M(-2.8%)
Jun 2005
-
$4.94 M(+44.6%)
Mar 2005
-
$3.42 M(+8.2%)
Sep 2004
-
$3.16 M(+8.7%)
Jun 2004
$9.42 M(+39.9%)
$2.91 M(+7.3%)
Mar 2004
-
$2.71 M(+25.4%)
Dec 2003
-
$2.16 M(+31.9%)
Sep 2003
-
$1.64 M(-29.8%)
Jun 2003
$6.73 M(+66.6%)
$2.33 M(+22.9%)
Mar 2003
-
$1.90 M(+61.4%)
Dec 2002
-
$1.18 M(+2.7%)
Sep 2002
-
$1.15 M(-23.2%)
Jun 2002
$4.04 M(+49.4%)
$1.49 M(+64.1%)
Mar 2002
-
$909.60 K(+30.8%)
Dec 2001
-
$695.30 K(-27.1%)
Sep 2001
-
$953.30 K(+70.6%)
Jun 2001
$2.70 M(+68.4%)
-
Dec 2000
-
$558.80 K
Jun 2000
$1.61 M
-

FAQ

  • What is Fennec Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals annual operating expenses year-on-year change?
  • What is Fennec Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals quarterly operating expenses year-on-year change?

What is Fennec Pharmaceuticals annual total operating expenses?

The current annual operating expenses of FENC is $33.05 M

What is the all time high annual operating expenses for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high annual total operating expenses is $33.05 M

What is Fennec Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, FENC annual total operating expenses has changed by +$8.86 M (+36.65%)

What is Fennec Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of FENC is $10.84 M

What is the all time high quarterly operating expenses for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high quarterly total operating expenses is $11.69 M

What is Fennec Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, FENC quarterly total operating expenses has changed by -$853.00 K (-7.29%)